Authors:
BUONAVOGLIA D
FASANELLA A
SAGAZIO P
TEMPESTA M
IOVANE G
BUONAVOGLIA C
Citation: D. Buonavoglia et al., PERSISTENCE OF ANTIBODIES TO MYCOPLASMA-AGALACTIAE IN VACCINATED SHEEP, The New microbiologica, 21(2), 1998, pp. 209-212
Authors:
PANARO MA
FASANELLA A
LISI S
MITOLO V
ANDRIOLA A
BRANDONISIO O
Citation: Ma. Panaro et al., EVALUATION OF NITRIC-OXIDE PRODUCTION BY LEISHMANIA INFANTUM-INFECTEDDOG MACROPHAGES, Immunopharmacology and immunotoxicology, 20(1), 1998, pp. 147-158
Authors:
JESKE W
LEWIS BE
SZATKOWSKI E
FASANELLA A
HAAS S
WALENGA JM
PIFARRE R
Citation: W. Jeske et al., DEVELOPMENT OF A FLOW CYTOMETRIC ASSAY FOR THE LABORATORY DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA, Thrombosis and haemostasis, 1997, pp. 1159-1159
Authors:
FASANELLA A
HOPPENSTEADT D
WOLF H
BERMES EW
Citation: A. Fasanella et al., PHARMACOKINETICS OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD, Thrombosis and haemostasis, 1997, pp. 1672-1672
Authors:
WALENGA JM
JESKE W
LEWIS BE
FABBRINI N
YANG L
SZATKOWSKI E
FASANELLA A
HAAS S
MESSMORE HL
PIFARRE R
Citation: Jm. Walenga et al., VALIDITY OF THE LABORATORY METHODS FOR THE DIAGNOSIS OF HIT - COMPARATIVE-STUDIES ON C-14 SEROTONIN RELEASE, ANTI-HEPARIN PLATELET FACTOR-4ANTIBODIES, PLATELET AGGREGOMETRY, LUMINESCENCE AGGREGOMETRY AND FLOWCYTOMETRIC METHODS, Thrombosis and haemostasis, 1997, pp. 1840-1840
Authors:
LEITZ H
WALENGA JM
FABBRINI N
LEWIS BE
FASANELLA A
MESSMORE HL
PIFARRE R
Citation: H. Leitz et al., PRE-EXISTENCE OF ANTI-PF4-HEPARIN ANTIBODIES IN PATIENTS NOT EXPOSED TO HEPARINS - RELEVANCE TO CLINICAL THROMBOCYTOPENIA, Thrombosis and haemostasis, 1997, pp. 2302-2302
Authors:
HOPPENSTEADT D
LEWIS BE
FABBRINI N
LEITZ H
FASANELLA A
MESSMORE HL
SCHWARZ R
WALENGA JM
Citation: D. Hoppensteadt et al., FUNCTIONAL FACTOR-X LEVELS AS A MEANS TO ASSESS THE REVEL OF ORAL ANTICOAGULATION IN PATIENTS RECEIVING ANTITHROMBIN DRUGS, Thrombosis and haemostasis, 1997, pp. 2607-2607
Authors:
GALBRAITH E
WRONA L
LEYA F
GRASSMAN E
HOPPENSTEADT D
FASANELLA A
WOLF H
Citation: E. Galbraith et al., LONG-TERM COMPLIANCE AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARIN IN PATIENTS TREATED WITH HIGH-DOSE CERTOPARIN FOR THE PREVENTION OF POST PTCA RESTENOSIS, Thrombosis and haemostasis, 1997, pp. 2800-2800
Authors:
JAY A
JESKE WP
FASANELLA A
WOOD J
BAKHOS M
WALENGA JM
Citation: A. Jay et al., MOLECULAR-WEIGHT AND NATURAL SYNTHETIC SOURCE OF HEPARIN RELATED TO PLATELET ACTIVATION AND AGGREGATION IN HEPARIN-INDUCED THROMBOCYTOPENIA/, Blood, 90(10), 1997, pp. 2988-2988
Authors:
JESKE WP
HAAS S
WOOD J
FASANELLA A
MESSMORE HL
AMIRAL J
BAKHOS M
WALENGA JM
Citation: Wp. Jeske et al., CROSS-REACTIVITY OF LOW-MOLECULAR-WEIGHT HEPARINS WITH ANTI-PF4-HEPARIN ANTIBODIES AS MEASURED USING THE SEROTONIN RELEASE ASSAY, Blood, 90(10), 1997, pp. 2989-2989
Authors:
WALENGA JM
JESKE WP
FASANELLA A
LEWIS BE
SCHWARZ R
BAKHOS M
Citation: Jm. Walenga et al., RELEVANCE OF CURRENT LABORATORY METHODS TO THE CLINICAL OUTCOME OF HEPARIN-INDUCED THROMBOCYTOPENIA - RESULTS OF THE ARG-911 TRIAL, Blood, 90(10), 1997, pp. 2047-2047
Authors:
BRANDONISIO O
PANUNZIO M
FALIERO SM
CECI L
FASANELLA A
PUCCINI V
Citation: O. Brandonisio et al., EVALUATION OF POLYMORPHONUCLEAR CELL AND MONOCYTE FUNCTIONS IN LEISHMANIA INFANTUM-INFECTED DOGS, Veterinary immunology and immunopathology, 53(1-2), 1996, pp. 95-103
Authors:
FASANELLA A
HOPPENSTEADT DA
WOLF H
BERMES EW
FAREED J
Citation: A. Fasanella et al., PHARMACOKINETICS (PK) OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD, Clinical chemistry, 42(6), 1996, pp. 409-409
Authors:
JESKE W
HOPPENSTEADT D
BERMES EW
FASANELLA A
FAREED J
Citation: W. Jeske et al., SPECIFIC QUANTITATION OF HEPARIN-RELEASABLE MULTIDOMAIN KUNITZ-TYPE INHIBITOR (TFPI) DURING PROPHYLACTIC AND THERAPEUTIC USE OF ANTICOAGULANTS, Clinical chemistry, 42(6), 1996, pp. 410-410
Authors:
FASANELLA A
HOPPENSTEADT D
WOLF H
BERMES EW
FAREED J
Citation: A. Fasanella et al., PHARMACOKINETICS (PK) OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LWMHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD, Blood, 88(10), 1996, pp. 3050-3050
Citation: A. Fasanella et al., CERNUELLA-VIRGATA (MOLLUSCA, GASTROPODA, PULMONATA) INTERMEDIATE SNAIL HOST FOR DICROCOELIUM-DENDRITICUM (RUDOLPHI, 1819) IN APULIA REGION,ITALY, Parasite, 2(3), 1995, pp. 331-333
Citation: Da. Hoppensteadt et al., EFFECT OF PROTAMINE ON HEPARIN-RELEASABLE TFPI ANTIGEN LEVELS IN NORMAL VOLUNTEERS, Thrombosis research, 79(3), 1995, pp. 325-330
Authors:
HOPPENSTEADT DA
WALENGA JM
FASANELLA A
JESKE W
FAREED J
Citation: Da. Hoppensteadt et al., TFPI ANTIGEN LEVELS IN NORMAL HUMAN VOLUNTEERS AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION OF UNFRACTIONATED HEPARIN AND A LOW-MOLECULAR-WEIGHT HEPARIN, Thrombosis research, 77(2), 1995, pp. 175-185
Citation: V. Puccini et al., EFFICACY OF MOXIDECTIN AGAINST ESTRUS-OVIS LARVAE IN NATURALLY INFESTED SHEEP, Veterinary record, 135(25), 1994, pp. 600-601
Authors:
FABBRINI N
KOZA M
HOPPENSTEADT D
WALENGA JM
FASANELLA A
MESSMORE H
FAREED J
Citation: N. Fabbrini et al., VALIDATION OF HEPTEST AND A MODIFIED (HEPTEST-HI) IN MONITORING THERAPEUTIC ANTICOAGULATION BY HEPARINS, Thrombosis and haemostasis, 69(6), 1993, pp. 1109-1109
Authors:
KOZA M
IYER L
KHENKINA Y
FASANELLA A
WALENGA JM
PIFARRE R
FAREED J
Citation: M. Koza et al., PROGRESSIVE ACCUMULATION OF R-HIRUDIN AFTER REPEATED SUBCUTANEOUS ADMINISTRATION - POTENTIAL IMPLICATIONS IN THE PROPHYLAXIS OF DVT, Thrombosis and haemostasis, 69(6), 1993, pp. 1301-1301